SANOFI DIABETE

Contact PR

To use this feature, join Babbler easily !

Nice to see you again !

Download this content

Fill in this form and allow the PR contact who posted this content to identify you.

Invalid email address
Press release

Moving from RCTs to innovative methodologies in real world evidence
timer minutes reading time minute reading time

Copy link
moving-from-rcts-to-innovative-methodologies-in-real-world-evidence

Click to get original image size

Why does RWE matter? Because outcomes matter! As a pioneer in real-world evidence (RWE) in diabetes, Sanofi has been building a large set of real world data for its insulins. Medical outcomes are defined by the relationship that exists between patient biology, patient behavior and healthcare practices. It is through RWE that we are able to gain a fuller picture of how our interventions truly affect those outcomes in real life. Sanofi’s RWE program contributes to the continuum of clinical research bridging the gap between randomized controlled trials (RCTs) and real life.

  • Bien-être
  • Médecine
  • Nutrition
  • Santé